Jefferies Reiterates Buy on LifePoint Hospitals

Jefferies is out with its report today on LifePoint Hospitals LPNT, reiterating Buy. In its report, Jefferies writes, "LPNT's new $250 million share repurchase plan could take down 14% of the shares outstanding and add as much $0.48 per share to annualized earnings . This announcement also sends a very strong signal about Q3 EPS. Our PT remains $45, but we believe we could see the stock make a near-term move towards $38-$39. Reiterate Buy." At the time of posting, shares of LPNT were trading at $34.83, down 0.40% from Friday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorReiterationAnalyst RatingsHealth CareHealth Care FacilitiesJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!